NCT05791344View on ClinicalTrials.gov

Intra-procedural ECG Changes During TAVR

TerminatedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

June 21, 2023

Primary Completion Date

July 23, 2024

Study Completion Date

December 31, 2024

Conditions
Transcatheter Aortic Valve ReplacementConduction Disturbance
Interventions
DEVICE

ECG monitoring

Intra-procedural ECG changes during TAVR

Trial Locations (1)

10065

The Weill Cornell Medicine, New York

Sponsors

Lead Sponsor

Cara Medical Ltd
All Listed Sponsors
lead

Cara Medical Ltd

INDUSTRY

NCT05791344 - Intra-procedural ECG Changes During TAVR | Biotech Hunter | Biotech Hunter